Day: August 6, 2024

Lantronix Inc. Wins 2024 IoT Evolution Product of the Year Award From IoT Evolution World Magazine

Lantronix’s Percepxion Cloud Software Platform Honored as One of the Most Innovative IoT Products IRVINE, Calif., Aug. 06, 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in Compute and Connectivity IoT solutions, is proud to announce that its Percepxion™ Cloud IoT Edge Solutions platform has been honored with the prestigious 2024 IoT Evolution Product of the Year Award by IoT Evolution World, the leading online publication in IoT technologies. This esteemed award celebrates the most groundbreaking products and solutions in IoT as selected by the editors of IoT Evolution World. For Lantronix, being recognized underscores our unwavering commitment to advancing business efficiency and fostering innovation in the IoT sector with cutting-edge technology. Since its launch in February 2024, the Percepxion...

Continue reading

DIRTT Unveils Major ICE® Software Update, Transforming User Experience and Project Management

CALGARY, Alberta, Aug. 06, 2024 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company”) (TSX: DRT; OTC: DRTTF), a leader in industrialized construction, today announced the release of ICE Manager, the most significant update to its industry-leading software platform to date. This software update introduces two key components: the new ICE Manager and the Design Editor application, both developed to revolutionize user engagement with the ICE platform. These advancements streamline the update process and enable continuous value delivery, positioning DIRTT’s partners and clients at the forefront of industrialized construction technology. “The release of ICE Manager is an incredibly exciting milestone. This modernization of the ICE Software will ensure it remains the best specification and configuration...

Continue reading

American Hotel Income Properties REIT LP Reports Q2 2024 Results With 5.1% RevPAR Growth

VANCOUVER, British Columbia, Aug. 06, 2024 (GLOBE NEWSWIRE) — American Hotel Income Properties REIT LP (“AHIP”, or the “Company”) (TSX: HOT.UN, TSX: HOT.U, TSX: HOT.DB. V), today announced its financial results for the three and six months ended June 30, 2024. All amounts presented in this news release are in United States dollars (“U.S. dollars”) unless otherwise indicated. 2024 SECOND QUARTER HIGHLIGHTS Diluted FFO per unit (1) and normalized diluted FFO per unit (1) were $0.12 and $0.10, respectively, for the second quarter of 2024, compared to $0.19 and $0.14 for the same period of 2023. RevPAR (1) increased 5.1% to $103 for the second quarter of 2024, compared to $98 for the same period of 2023. ADR (1) increased 3.0% to $137 for the second quarter of 2024, compared to $133 for the same period of 2023. Occupancy (1) was 75.4%...

Continue reading

Melcor Developments announces second quarter results, declares quarterly dividend of $0.11 per share

EDMONTON, Alberta, Aug. 06, 2024 (GLOBE NEWSWIRE) — Melcor Developments Ltd. (“Melcor”) (TSX: MRD), an Alberta-based real estate development and asset management company, today reported results for the second quarter ended June 30, 2024. The second quarter Management Discussion & Analysis (MD&A) and Condensed Interim Financial Statements are available on our website (www.melcor.ca) under Investors, or on SEDAR+ (www.sedarplus.ca). Timothy Melton, Melcor’s Executive Chair and Chief Executive Officer, commented: “Melcor is pleased to report results for the second quarter of 2024. Revenue for the quarter increased 6.8% to $69.71 million (Q2-2023: $65.25 million), and 17.9% to $119.46 million year-to-date (2023: $101.32 million). Funds from operations increased 15.4% to $20.12 million in the quarter (Q2-2023:...

Continue reading

Orezone Reports Second Quarter 2024 Results

All dollar amounts are in USD unless otherwise stated and abbreviation “M” means million VANCOUVER, British Columbia, Aug. 06, 2024 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (“Orezone” or “Company”) reported its operational and financial results for the three and six months ended June 30, 2024. The Company will host a conference call and webcast on August 7, 2024 commencing at 8:00am PT to discuss its Q2-2024 results. Additional details are provided at the end of this press release. Patrick Downey, President and CEO, commented “Second quarter results were impacted by lower-than-expected grid power availability, and by lower scheduled head grades per the 2024 mine plan. Operating and financial results are anticipated to be significantly stronger in the second half of 2024 as mining ramps up in our newest...

Continue reading

Maxim Power Corp. Announces 2024 Second Quarter Financial and Operating Results

CALGARY, Alberta, Aug. 06, 2024 (GLOBE NEWSWIRE) — Maxim Power Corp. (“MAXIM” or the “Corporation”) (TSX: MXG) announced today the release of financial and operating results for the second quarter ended June 30, 2024. The unaudited condensed consolidated interim financial statements, accompanying notes and Management’s Discussion and Analysis (“MD&A”) will be available on SEDAR+ and on MAXIM’s website on August 6, 2024. All figures reported herein are Canadian dollars unless otherwise stated. FINANCIAL HIGHLIGHTS     Three Months Ended June 30,   Six Months EndedJune 30,   ($ in thousands except per share amounts) 2024      2023      2024     2023     Revenue 17,007     –     51,775     –     Net income 1,056     5,964     11,543     13,715     Earnings per share – basic 0.02     0.12     0.23     0.27     Earnings...

Continue reading

Aeterna Zentaris Inc. Announces Name Change to COSCIENS Biopharma Inc.

TORONTO, ONTARIO, Aug. 06, 2024 (GLOBE NEWSWIRE) — COSCIENS Biopharma Inc. (formerly Aeterna Zentaris Inc.) (NASDAQ: AEZS) (TSX: AEZS) (“COSCIENS” or the “Company”), a specialty biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries, today announces that the Company’s name has been changed from “Aeterna Zentaris Inc.” to “COSCIENS Biopharma Inc.”, effective as of August 6, 2024 (the “Name Change”). In addition, the Company announces that, effective as of August 9, 2024, the Company’s common shares (the “Common Shares”) will begin trading on the Toronto Stock Exchange (the “TSX”) and NASDAQ Capital Market (the “NASDAQ”) under the trading symbol “CSCI” and will concurrently cease...

Continue reading

Mondee to Hold Webcast on Second Quarter 2024 Financial Results and Anticipated New Financing on August 14, 2024

AUSTIN, Texas, Aug. 06, 2024 (GLOBE NEWSWIRE) — Mondee Holdings, Inc. (Nasdaq: MOND) (“Mondee” or the “Company”), a leading travel marketplace and artificial intelligence (AI) technology company, announced that it will hold its webcast on the second quarter 2024 financial results for the period ended June 30, 2024 and its anticipated new financing, on Wednesday, August 14, 2024. A release shall accompany the webcast. The Company is rescheduling the webcast as a result of an agreement on principle terms with lenders for a refinancing which it is working diligently to close. The Company will host the live audio webcast at 5:30 a.m. (PT) / 7:30 a.m. (CT) / 8:30 a.m. (ET) on Wednesday, August 14, 2024, to discuss its financial results and anticipated long-term financing with the investment community. The webcast is expected to last...

Continue reading

Stingray Reports First Quarter Results for Fiscal 2025

Broadcast and Commercial Music Revenues Soar with 17.1% Organic Growth YoY Revenues increased 12.8% to $89.1 million in the first quarter of fiscal 2025 from $79.0 million in the first quarter of 2024; Adjusted EBITDA(1) improved 9.9% to $31.1 million in the first quarter of 2025 from $28.3 million in the first quarter of 2024. Adjusted EBITDA(1) by segment was $23.0 million or 40.4% of revenues for Broadcasting and Commercial Music, $9.9 million or 30.8% of revenues for Radio, and $(1.8) million for Corporate; Net income totaled $7.3 million, or $0.11 per share, in the first quarter of 2025 compared to $14.1 million, or $0.20 per share, in the first quarter of 2024; Adjusted net income(1) increased 17.2% to $13.9 million, or $0.20 per share, in the first quarter of 2025 from $11.9 million, or $0.17 per share, in the same period of 2024; Cash...

Continue reading

Agios to Receive $1.1 Billion in Milestone Payments Following FDA Approval of Vorasidenib

– Agios Expects to Receive $905 Million Payment from Royalty Pharma and $200 Million Payment from Servier in Q3 2024; Payments Increase Agios’ Pro-Forma Cash Position as of June 30, 2024, to $1.7 Billion – – Strong Cash Position to Enable Agios to Prepare for Potential PYRUKYND® (Mitapivat) Launches in Thalassemia in 2025 and Sickle Cell Disease in 2026 and Drive Pipeline Progress – CAMBRIDGE, Mass., Aug. 06, 2024 (GLOBE NEWSWIRE) — Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that the Company will receive a total of $1.1 billion in milestone payments following the U.S. Food and Drug Administration (FDA) approval of vorasidenib for adult and pediatric patients 12 years and older with Grade 2 astrocytoma or...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.